Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1753 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA Warns Against Maalox Product Mix-Ups

The two products are intended for the relief of different symptoms and contain different active ingredients. Maalox Total Relief is an upset stomach reliever and anti-diarrheal medication, while

FDA Accepts Jazz’s Filing For JZP-6

Sodium oxybate is the sodium salt form of gamma-hydroxybutyrate, an endogenous neurotransmitter and metabolite of GABA. Reportedly, based on a standard 10-month review, the target date for the

FDA Gives Nod To Roche’s Rituxan

Rituxan is intended for patients with CLL who are beginning chemotherapy for the first time and for those who have not responded to other cancer drugs for CLL.

Opko Health Acquires Pharmacos Exakta

Opko has acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of Opko Common Stock. Phillip Frost, chairman and CEO of Opko,

Gentel Unveils Proteomics Multi-System

Gentel Biosciences said that the integrated Proteomics Multi-System includes a high-resolution scanner along with a laptop computer preconfigured with image-capture and analysis software capable of data extraction and